AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase
(Reuters) -AstraZeneca said on Tuesday it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals Inc for about $2 bi..
Headlines
All Posts

(Reuters) -AstraZeneca said on Tuesday it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals Inc for about $2 bi..
Headlines

(Reuters) – The artificial intelligence boom has hit the crypto market with a bang. Coins linked to AI-focused crypto projects h..
Headlines

(Reuters) – The European Patent Office (EPA) received a record number of patent applications last year, with the biggest share o..
Headlines

LONDON (Reuters) – Kate, Britain’s Princess of Wales, has been shown looking fit and healthy in the first video taken of h..
Headlines

NEW YORK/LONDON (Reuters) -Global stocks rose on Monday while Treasury yields crept higher ahead of this week’s raft of central ..
Headlines

(Reuters) – Popular messaging platform Telegram raised $330 million through bond sales last week, founder and CEO Pavel Durov sa..
Headlines

In today’s highly competitive business landscape, gaining the trust of potential customers is crucial for success. One powerful ..
Business

LONDON (Reuters) – The London Bullion Market Association (LBMA), which sets standards for the world’s most established gold ma..
Headlines

NEW YORK/LONDON (Reuters) – Global stocks jumped on Monday while Treasury yields crept higher as investors looked ahead to a raf..
Headlines

BEIJING (Reuters) –China has changed the rules for consumer finance firms for the first time in a decade, setting a higher bar ..
Finance